|
Molecule discovered to be key to pain sensitivity
October 23, 2006Gene variation identifies those with higher pain threshold, lower risk of chronic pain
Sensitivity to pain and the risk of developing chronic pain appear to be influenced by levels of a molecule known to be required for the production of major neurotransmitters. In the November issue of Nature Medicine, an international research team based at Massachusetts General Hospital (MGH) describes this unexpected role for the molecule called BH4 and their findings that a particular set of variations in a human gene involved in synthesizing the molecule appears to reduce pain sensitivity.
"This is the first evidence of a genetic contribution to the risk of developing neuropathic pain in humans. The pain-protective gene sequence, which is carried by about 20 to 25 percent of the population, appears to be a marker both for less pain sensitivity and a reduced risk for chronic pain," says senior author Clifford Woolf, MD, PhD, director of the Neural Plasticity Research Group in the MGH Department of Anesthesia and Critical Care. "Identifying those at greater risk of developing chronic pain in response to medical procedures, trauma or diseases could lead to new preventive strategies and potential treatments."
Previous studies in animals have shown that specific strains or related groups of rodents have significant differences in their risk of developing either neuropathic pain, which results from nerve damage, or inflammatory pain, associated with the immune system's response to injuries or conditions like arthritis. But except for some rare inherited conditions, there has been no evidence that genetics contributed to the risk of neuropathic pain in humans.
The research team had previously used gene chips to find that nerve damage in rats altered the regulation of several hundred genes in associated nerve cells. They began the current study by searching through these genes to find any associated with common metabolic pathways and found that three genes that increased expression in response to nerve damage encoded enzymes involved in the production and recycling of BH4, which is essential for the production of serotonin, dopamine, norepinephrine and nitric oxide. Tests in rat models found that the BH4-synthesizing enzymes were activated in injured sensory neurons and that substances known to inhibit those enzymes reduced pain, acting as analgesics. Directly injecting BH4 or a similar molecule increased the animal's response to several painful stimuli.
As a result of the animal studies, the researchers hypothesized that particular variations of human genes involved in the regulation of BH4 might be associated with different responses to pain. Searching for alterations in the gene for GCH1, the human version of the key BH4-controlling enzyme, they genotyped tissues from 168 patients who had participated in an earlier study of spinal disk surgery. One specific GCH1 haplotype-a set of variations in the gene that are inherited together-was more common in study participants who reported less neuropathic pain in the year after their surgery.
To see if that haplotype had a similar association with other types of pain, the researchers studied almost 400 healthy volunteers, who participated in tests of their response to various slightly painful experimental stimuli. Again, those participants with the protective GCH1 haplotype-which the investigators showed reduces the production of BH4-also reported less pain, and volunteers with two copies of the protective sequence were even less sensitive to pain.
"Our results tell us that BH4 is a key pain-producing molecule - when it goes up, patients experience pain, and if it is not elevated, they will have less pain," says Woolf. "The data also suggest that individuals who say they feel less pain are not just stoics but genuinely have inherited a molecular machinery that reduces their perception of pain. This difference results not from personality or culture, but real differences in the biology of the sensory nervous system.
"Now we need to identify what regulates the switching on of BH4-controlling enzymes after nerve injury and how BH4 alters the excitability of pain fibers. We also would like to see whether those with the protective haplotype might participate more frequently in potentially painful activities - such as extreme sports - or if they have reduced levels of pain in arthritis and other common conditions,\\\
Massachusetts General Hospital
Previous studies in animals have shown that specific strains or related groups of rodents have significant differences in their risk of developing either neuropathic pain, which results from nerve damage, or inflammatory pain, associated with the immune system's response to injuries or conditions like arthritis. But except for some rare inherited conditions, there has been no evidence that genetics contributed to the risk of neuropathic pain in humans.
The research team had previously used gene chips to find that nerve damage in rats altered the regulation of several hundred genes in associated nerve cells. They began the current study by searching through these genes to find any associated with common metabolic pathways and found that three genes that increased expression in response to nerve damage encoded enzymes involved in the production and recycling of BH4, which is essential for the production of serotonin, dopamine, norepinephrine and nitric oxide. Tests in rat models found that the BH4-synthesizing enzymes were activated in injured sensory neurons and that substances known to inhibit those enzymes reduced pain, acting as analgesics. Directly injecting BH4 or a similar molecule increased the animal's response to several painful stimuli.
As a result of the animal studies, the researchers hypothesized that particular variations of human genes involved in the regulation of BH4 might be associated with different responses to pain. Searching for alterations in the gene for GCH1, the human version of the key BH4-controlling enzyme, they genotyped tissues from 168 patients who had participated in an earlier study of spinal disk surgery. One specific GCH1 haplotype-a set of variations in the gene that are inherited together-was more common in study participants who reported less neuropathic pain in the year after their surgery.
To see if that haplotype had a similar association with other types of pain, the researchers studied almost 400 healthy volunteers, who participated in tests of their response to various slightly painful experimental stimuli. Again, those participants with the protective GCH1 haplotype-which the investigators showed reduces the production of BH4-also reported less pain, and volunteers with two copies of the protective sequence were even less sensitive to pain.
"Our results tell us that BH4 is a key pain-producing molecule - when it goes up, patients experience pain, and if it is not elevated, they will have less pain," says Woolf. "The data also suggest that individuals who say they feel less pain are not just stoics but genuinely have inherited a molecular machinery that reduces their perception of pain. This difference results not from personality or culture, but real differences in the biology of the sensory nervous system.
"Now we need to identify what regulates the switching on of BH4-controlling enzymes after nerve injury and how BH4 alters the excitability of pain fibers. We also would like to see whether those with the protective haplotype might participate more frequently in potentially painful activities - such as extreme sports - or if they have reduced levels of pain in arthritis and other common conditions,\\\
Massachusetts General Hospital
Neuropathic Pain News and Current Neuropathic Pain Events RSSPain treatment in the field: Good for soldiers' comfort and better for rebuilding troop strength
Noncombat-related acute and recurrent chronic pain are the leading causes of soldier attrition in modern war, with the return-to-duty rate as low as 2 percent when these soldiers are treated outside the theaters of operation.
Smoked cannabis proven effective in treating neuropathic pain
Smoked cannabis eased pain induced in healthy volunteers, according to a study by researchers at the University of California, San Diego (UCSD) Center for Medical Cannabis Research (CMCR.) However, the researchers found that less may be more.
Study finds role of mid-brain in integrating heart and respiratory response to exercise
For almost one hundred years the brain's "central command" system - whose charge includes controlling the body's cardiorespiratory response to exercise - has been pursued.
New technique holds promise for reducing back surgery failure
Texas researchers believe that they have discovered how to prevent many cases of the most common problem encountered by patients undergoing spine surgery: failed back surgery syndrome (FBSS).
Major breakthrough in the mechanism of myelin formation
The group of Dr. Michel Cayouette, researcher at Institut de recherches cliniques de Montréal (IRCM), and Dr. Jonah Chan, collaborator at the University of Southern California, will publish in the next issue of the prestigious scientific journal Science, the results of their study that could have a major impact on the treatment of diseases such as multiple sclerosis, and peripheral neuropathies.
USC researchers closer to cure for multiple sclerosis and other myelin-related diseases
A breakthrough finding on the mechanism of myelin formation by Jonah Chan, assistant professor of cell and neurobiology at the Keck School of Medicine of the University of Southern California, could have a major impact on the treatment of diseases such as multiple sclerosis and demyelination as a result of spinal cord injuries.
Gene variation affects pain sensitivity and risk of chronic pain
A new NIH-funded study shows that a specific gene variant in humans affects both sensitivity to short-term (acute) pain in healthy volunteers and the risk of developing chronic pain after one kind of back surgery.
Cooling analgesia harnessed to relieve chronic pain
By experimentally activating a special protein involved in mediating sensations of coolness, researchers have made a breakthrough in understanding how the body's nervous system can be stimulated to relieve chronic pain.
Study finds nerve damage in previously mysterious chronic pain syndrome
Researchers at Massachusetts General Hospital (MGH) have found the first evidence of a physical abnormality underlying the chronic pain condition called reflex sympathetic dystrophy or complex regional pain syndrome-I (CRPS-I).
Master genetic switch found for chronic pain
In experiments with mice, researchers have found that eliminating what appears to be a master genetic switch for the development of pain-sensing neurons knocks out the animals' response to "neuropathic pain."
More Neuropathic Pain News Articles
 | Striking Back (Striking Back The Trigeminal Neuralgia and Face Pain Handbook 2004) by George Weigel |
 | Emerging Strategies for the Treatment of Neuropathic Pain |
 | With Great Mercy by Kathy Gilbert Taylor |
 | Neuropathic Pain (Oxford Pain Management Library S.) |
 | Central Neuropathic Pain: Focus on Poststroke Pain |
| A Clinical Guide to Neuropathic Pain by MD Bradley S. Galer, Ph.D Robert H. Dworkin | |
 | Functional Neuroanatomy of Pain (Advances in Anatomy, Embryology and Cell Biology) by K.G. Usunoff, A. Popratiloff, O. Schmitt, A. Wree |
| Neuropathic disorder patients getting inappropriate pain Rx.(Geriatric Psychiatry): An article from: Clinical Psychiatry News by Kerri Wachter | |
| New Directions in Neuropathic Pain by N. Attal, Bruce Nicholson, J. Serra | |
| Superior to routine care: duloxetine effective for diabetic neuropathic pain.(Clinical Rounds): An article from: Internal Medicine News by Steve Perlstein |
| © 2008 BrightSurf.com |